Autoantibodies clearly contribute to tissue inflammation in systemic lupus erythematosus. In
order to therapeutically target B cells making pathogenic autoantibodies, it is necessary to …

Two distinct subsets of CD4+ Foxp3+ regulatory T (Treg) cells have been described based
on the differential expression of Helios, a transcription factor of the Ikaros family. Efforts to …

The c-Src tyrosine kinase, Csk, physically interacts with the intracellular phosphatase Lyp (encoded
by PTPN22) and can modify the activation state of downstream Src kinases, such as …

Objective Phosphopeptide P140 (Lupuzor) is an inhibitor of autophagy currently being
evaluated in late‐stage clinical trials for the treatment of lupus. This study was undertaken to …

Objective. Hydroxychloroquine (HCQ) and chloroquine (CQ) are key drugs in systemic lupus
(SLE) and related diseases. Retinal toxicity remains the most worrisome complication. We …

Materials and methods: We searched MEDLINE and PubMed for case reports of SLE and
MG. We also calculated MG incidence within our clinical SLE cohort (females only). Results: …

Objective Hydroxychloroquine (HCQ) and chloroquine (CQ) are key drugs in systemic lupus
(SLE) and related diseases. Retinal toxicity remains the most worrisome complication. We …

Systemic lupus erythematosus (SLE) is a disease caused by autoantibodymediated damage
in multiple target organs. The hallmark autospecificity in SLE is nuclear antigen with double …

To the Editor: It was inspiring to see Sanchez et al 1 hold the allergy community to a higher
standard by using the data of Kolkhir et al 2 to determine the sensitivity, specificity, positive …

Objective: To evaluate the feasibility and potential benefits of initiating a yoga program
adapted for persons with systemic lupus erythematosus (SLE). Methods: We conducted a …